Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Humoral immunity is involved in the development of pericentral fibrosis after pediatric live donor liver transplantation.

Yamada H, Kondou H, Kimura T, Ikeda K, Tachibana M, Hasegawa Y, Kiyohara Y, Ueno T, Miyoshi Y, Mushiake S, Ozono K.

Pediatr Transplant. 2012 Dec;16(8):858-65. doi: 10.1111/j.1399-3046.2012.01781.x. Epub 2012 Aug 29.

PMID:
22931465
2.

Progressive graft fibrosis and donor-specific human leukocyte antigen antibodies in pediatric late liver allografts.

Miyagawa-Hayashino A, Yoshizawa A, Uchida Y, Egawa H, Yurugi K, Masuda S, Minamiguchi S, Maekawa T, Uemoto S, Haga H.

Liver Transpl. 2012 Nov;18(11):1333-42. doi: 10.1002/lt.23534.

3.

Lobular damage caused by cellular and humoral immunity in liver allograft rejection.

Sawada T, Shimizu A, Kubota K, Fuchinoue S, Teraoka S.

Clin Transplant. 2005 Feb;19(1):110-4.

PMID:
15659143
4.

Acute humoral rejection and C4d immunostaining in ABO blood type-incompatible liver transplantation.

Haga H, Egawa H, Fujimoto Y, Ueda M, Miyagawa-Hayashino A, Sakurai T, Okuno T, Koyanagi I, Takada Y, Manabe T.

Liver Transpl. 2006 Mar;12(3):457-64.

5.

An immunohistochemical evaluation of C4d deposition in pediatric inflammatory liver diseases.

Bouron-Dal Soglio D, Rougemont AL, Herzog D, Soucy G, Alvarez F, Fournet JC.

Hum Pathol. 2008 Jul;39(7):1103-10. doi: 10.1016/j.humpath.2007.12.014.

PMID:
18570976
6.

The histopathology of lung allograft dysfunction associated with the development of donor-specific HLA alloantibodies.

Yousem SA, Zeevi A.

Am J Surg Pathol. 2012 Jul;36(7):987-92. doi: 10.1097/PAS.0b013e31825197ae.

PMID:
22510758
7.

The impact of C4d staining as a humoral injury marker.

Kara M, Demir F, Ata P, Ozel L, Gumrukcu G, Unal E, Canbakan M, Gucun M, Esadoglu V, Ozdemir E, Cemel H, Titiz MI.

Transplant Proc. 2012 Jul-Aug;44(6):1694-6. doi: 10.1016/j.transproceed.2012.05.029.

PMID:
22841245
8.

Postoperative flow cytometry crossmatch in living donor liver transplantation: clinical significance of humoral immunity in acute rejection.

Kasahara M, Kiuchi T, Takakura K, Uryuhara K, Egawa H, Asonuma K, Uemoto S, Inomata Y, Ohwada S, Morishita Y, Tanaka K.

Transplantation. 1999 Feb 27;67(4):568-75.

PMID:
10071029
9.

Significance of central perivenulitis in pediatric liver transplantation.

Abraham SC, Freese DK, Ishitani MB, Krasinskas AM, Wu TT.

Am J Surg Pathol. 2008 Oct;32(10):1479-88. doi: 10.1097/PAS.0b013e31817a8e96.

PMID:
18708942
10.

Significance of complement split product C4d in ABO-compatible liver allograft: diagnosing utility in acute antibody mediated rejection.

Ali S, Ormsby A, Shah V, Segovia MC, Kantz KL, Skorupski S, Eisenbrey AB, Mahan M, Huang MA.

Transpl Immunol. 2012 Jan;26(1):62-9. doi: 10.1016/j.trim.2011.08.005. Epub 2011 Sep 1.

PMID:
21907804
11.

Characterization of c4d immunostaining utilizing paraffin-embedded tissue of nonpresensitized pediatric heart transplant patients.

Galambos C, Feingold B, Webber SA.

Pediatr Dev Pathol. 2008 May-Jun;11(3):181-4. Epub 2007 Aug 6.

PMID:
17990923
12.

Portal vein complications in pediatric living donor liver transplantation using left-side grafts.

Ueda M, Oike F, Kasahara M, Ogura Y, Ogawa K, Haga H, Takada Y, Egawa H, Tanaka K, Uemoto S.

Am J Transplant. 2008 Oct;8(10):2097-105. doi: 10.1111/j.1600-6143.2008.02360.x. Epub 2008 Aug 22.

13.

Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification.

Mauiyyedi S, Crespo M, Collins AB, Schneeberger EE, Pascual MA, Saidman SL, Tolkoff-Rubin NE, Williams WW, Delmonico FL, Cosimi AB, Colvin RB.

J Am Soc Nephrol. 2002 Mar;13(3):779-87.

14.

Positive C4d staining of the portal vein endothelium in the liver of patients with biliary atresia: a role of humoral immunity in ongoing liver fibrosis.

Fujisawa S, Muraji T, Sakamoto N, Hosaka N, Matsuda S, Kawakami H, Hirai M, Yanai T.

Pediatr Surg Int. 2014 Sep;30(9):877-81. doi: 10.1007/s00383-014-3553-3. Epub 2014 Jul 27.

PMID:
25064226
16.

Antibody-mediated rejection in the liver allograft.

Hübscher SG.

Curr Opin Organ Transplant. 2012 Jun;17(3):280-6. doi: 10.1097/MOT.0b013e328353584c. Review.

PMID:
22569512
17.

The effect of HLA mismatches, shared cross-reactive antigen groups, and shared HLA-DR antigens on the outcome after pediatric liver transplantation.

Sieders E, Hepkema BG, Peeters PM, TenVergert EM, de Jong KP, Porte RJ, Bijleveld CM, van den Berg AP, Lems SP, Gouw AS, Slooff MJ.

Liver Transpl. 2005 Dec;11(12):1541-9.

18.

Humoral heart rejection (severe allograft dysfunction with no signs of cellular rejection or ischemia): incidence, management, and the value of C4d for diagnosis.

Crespo-Leiro MG, Veiga-Barreiro A, Doménech N, Paniagua MJ, Piñón P, González-Cuesta M, Vázquez-Martul E, Ramirez C, Cuenca JJ, Castro-Beiras A.

Am J Transplant. 2005 Oct;5(10):2560-4.

19.

Clinical implications of flow cytometry crossmatch with T or B cells in living donor liver transplantation.

Takakura K, Kiuchi T, Kasahara M, Uryuhara K, Uemoto S, Inomata Y, Tanaka K.

Clin Transplant. 2001 Oct;15(5):309-16.

PMID:
11678956
20.

Clinical and pathological correlations of C4d immunostaining and its influence on the outcome of kidney transplant recipients.

Carpio VN, Rech C, Eickhoff EI, Pegas KL, Edelweiss MI, Gonçalves LF, Manfro RC, Veronese FV.

J Bras Nefrol. 2011 Jul-Sep;33(3):329-37.

Supplemental Content

Support Center